Please Click the link below to see the article
http://www.aafp.org/afp/2010/0715/p151.html
SORT: KEY RECOMMENDATIONS FOR PRACTICE
| CLINICAL RECOMMENDATION | EVIDENCE RATING | REFERENCES |
|---|---|---|
First-line treatment of diabetic peripheral neuropathic pain includes tricyclic antidepressants (e.g., amitriptyline, nortriptyline [Pamelor]). If these agents are contraindicated, newer anticonvulsants (e.g., gabapentin [Neurontin], pregabalin [Lyrica]) should be considered.
|
B
| |
Serotonin-norepinephrine reuptake inhibitors (e.g., venlafaxine [Effexor], duloxetine [Cymbalta]) or opiates and opiate analogs (e.g., morphine, tramadol [Ultram]) may be used if first-line treatments are unsuccessful.
|
B
| |
Topical treatments (e.g., capsaicin cream [Zostrix], lidocaine 5% patches [Lidoderm]) may be added to systemic treatments at any time.
|
B
|
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go tohttp://www.aafp.org/afpsort.xml.
Medications Used to Treat Diabetic Peripheral Neuropathic Pain
| DRUG* | DOSAGE | COST OF GENERIC (BRAND)† | COMMENTS |
|---|---|---|---|
Amitriptyline‡
|
10 to 150 mg at bedtime
|
$12 (NA)§
|
NNT = 1.3, NNH = 28 (major adverse events)
|
Nortriptyline‡ (Pamelor)
|
25 to 150 mg at bedtime
|
$13 ($692)§
|
NNH = 6 (minor adverse events)8||
|
Desipramine‡ (Norpramin)
|
25 to 150 mg at bedtime
|
$23 ($44)
| |
Pregabalin (Lyrica)
|
150 to 600 mg per day, divided into two or three doses
|
NA ($168)
|
NNT = 3.3, NNH = 3.79
|
300 mg twice per day
|
NNT = 4.010||
| ||
100 mg three times per day
|
NNT = 6.010||
| ||
50 mg three times per day
|
NNT = 19.110||
| ||
Gabapentin (Neurontin)
|
300 to 1,200 mg three times per day
|
$60 ($182)
|
NNT = 4.3, NNH = 3.711||
|
Carbamazepine (Tegretol)
|
200 to 600 mg twice per day
|
$10 ($86)§
|
NNT = 3.3, NNH = 1.99||
|
NNT = 2.5, NNH = 3.712
| |||
Venlafaxine, extended release (Effexor XR)
|
150 to 225 mg per day
|
$142 ($150)
|
NNT = 3.1, NNH = 16.2 (major adverse effect)
|
NNH = 9.6 (minor adverse effect)8
| |||
Duloxetine (Cymbalta)
|
60 to 120 mg per day
|
NA ($154)
| |
Morphine
|
15 to 120 mg per day
|
$17
| |
Oxycodone, controlled release (Oxycontin)
|
10 to 40 mg twice per day
|
$61 ($152)
|
NNT = 2.6 based on single small RCT16
|
Another RCT showed benefit17||
| |||
NNH = 816 (adverse effects led to withdrawal from study)
| |||
Tramadol (Ultram)
|
200 to 400 mg per day
|
$64 ($246)
|
NNT = 3.8, NNH = 7.7 (adverse effects led to withdrawal from study)18
|
Capsaicin cream (Zostrix)
|
0.075% topical cream four times per day
|
NA ($22 per 57-g tube)
|
NNT = 5.7 (adverse effects make blinded trials difficult)
|
NNH = 2.5 (local adverse effect)
| |||
NNH = 9.8 (adverse effects led to withdrawal from study)19
| |||
Lidocaine 5% patch (Lidoderm)
|
Up to three patches per day, each patch worn up to 12 hours; patches may be worn at the same time; a 12-hour drug-free interval is necessary
|
NA ($217 for one patch per day)
| |
l-carnitine
|
1,000 mg three times per day
|
$40
|
Review of two RCTs showed improved pain and nerve fiber regeneration22
|
Alpha-lipoic acid
|
600 mg per day
|
$10
|
Two RCTs showed conflicting results; long-term studies with oral formulation are needed23
|
Acupuncture
|
Types variable
|
$60 to 120 per treatment
| |
Frequency-modulated electromagnetic neural stimulation
|
30 minutes per day
|
Depends on cost of hardware
|
†—Estimated retail price of one month's treatment based on lowest dosage provided. Information obtained at http://www.drugstore.com (accessed April 23, 2010). Generic price listed first; brand price listed in parentheses..
‡— Adverse effects make blinding difficult; numerous adverse effects and contraindications.
§—In retail discount program; may be available at discounted prices ($10 or less for one month's treatment) at one or more national retail chains.
||—NNT based on diabetic peripheral neuropathic pain specifically (others based on generalized neuropathic pain).
Common Adverse Effects from Treatment for Diabetic Peripheral Neuropathic Pain
| DRUG | ADVERSE EFFECT | PATIENTS WHO EXPERIENCED EFFECT (%) |
|---|---|---|
Constipation
|
14
| |
Dizziness
|
28
| |
Dry mouth
|
90
| |
Somnolence
|
66
| |
Capsaicin cream (Zostrix)19
|
Cough
|
8
|
Skin irritation
|
54
| |
Constipation
|
9
| |
Diarrhea
|
6
| |
Fatigue
|
9
| |
Headache
|
10
| |
Nasopharyngitis
|
6
| |
Nausea
|
22
| |
Somnolence
|
8
| |
Sweating
|
6
| |
Gabapentin (Neurontin)11
|
Confusion
|
7
|
Diarrhea
|
10
| |
Dizziness
|
24
| |
Headache
|
10
| |
Nausea
|
8
| |
Somnolence
|
20
| |
Lidocaine 5% patch (Lidoderm)20
|
No adverse effects significantly different from placebo
|
—
|
Opiates14
|
Constipation
|
33
|
Dizziness
|
21
| |
Nausea
|
33
| |
Somnolence
|
29
| |
Vomiting
|
15
| |
Dizziness
|
7 to 28
| |
Edema
|
6 to 16
| |
Somnolence
|
5 to 13
| |
Weight gain
|
4 to 9
| |
Tramadol (Ultram)18
|
Constipation
|
22
|
Headache
|
17
| |
Nausea
|
23
| |
Somnolence
|
12
| |
Venlafaxine (Effexor)8
|
Anorexia
|
5
|
Dyspepsia
|
10
| |
Flatulence
|
6
| |
Impotence
|
5
| |
Insomnia
|
10
| |
Myalgia
|
5
| |
Nausea
|
10
| |
Sinusitis
|
7
| |
Somnolence
|
15
| |
Sweating
|
10
| |
Vomiting
|
5
|
No comments:
Post a Comment